Sales and Marketing

Showing 15 posts of 11527 posts found.

‘Rare Disease Day’ highlights need for research

February 29, 2012 Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire

 Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …

A wake-up call for big pharma

February 29, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma

The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …

Abbott buys into Galapagos’ RA candidate

February 29, 2012 Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …

LEO Pharma appoints new executive vice president

February 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …

Doctors don’t want rationing responsibility, finds survey

February 28, 2012 Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing

 A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …

Jon Linscott to head PAN Advertising

February 28, 2012 Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising

Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies.   Linscott …

Glivec cleared for longer use in GIST patients

February 28, 2012 Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis

Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …

Witty hits out at ‘systematic delays’ to medicines

February 27, 2012 Sales and Marketing Europe, GSK, NICE, austerity

 GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …

Janssen launches hep C support programme

February 27, 2012 Medical Communications, Sales and Marketing BUPA, Copegas, Incivo, Janssen, Pegasys, hep C

Janssen has launched a hepatitis C support programme for patients in the UK to help with medicine adherence and healthy …

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …

EMA accepts Genzyme MS drug for review

February 24, 2012 Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …

Care regulator chief steps down

February 24, 2012 Sales and Marketing CQC, Cynthia Bower, Mid Staffs, reforms

The head of the Care Quality Commission Cynthia Bower has resigned from her post, amid growing pressure from the government. …

Genzyme to close UK site

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …

The NHS, a postcard from the frontline

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …
The Gateway to Local Adoption Series

Latest content